missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. 18767162

4-1BB/TNFRSF9/CD137 Antibody (LOB12), Janelia Fluor™ 549, Novus Biologicals™

Rat Monoclonal Antibody

Brand:  Novus Biologicals NB100-63415JF549

Product Code. 18767162

  • € 583.00 / 125µL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

4-1BB/TNFRSF9/CD137 Monoclonal antibody specifically detects 4-1BB/TNFRSF9/CD137 in Mouse samples. It is validated for Flow Cytometry
TRUSTED_SUSTAINABILITY
Specifications

Specifications

4-1BB/TNFRSF9/CD137
Monoclonal
Janelia Fluor 549
4-1BB, 4-1BB ligand receptor, CD137 antigen, CD137MGC2172, CDw137, FLJ43501, ILAhomolog of mouse 4-1BB, induced by lymphocyte activation (ILA), interleukin-activated receptor, homolog of mouse Ly63, receptor protein 4-1BB, T cell antigen ILA, T-cell antigen 4-1BB homolog, T-cell antigen ILA, tumor necrosis factor receptor superfamily member 9, tumor necrosis factor receptor superfamily, member 9
Murine CD137 human Fc fusion protein
0.125 mL
Apoptosis, Cancer, Cell Biology, Immune System Diseases, Immunology, Stem Cells
3604
Store at 4°C in the dark.
IgG2a
Flow Cytometry
LOB12
50mM Sodium Borate
Rat
Protein G purified
RUO
Primary
Mouse
Purified
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.